Idiopathic Macular Hole
10
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
10%
1 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Intraocular Gas Tamponade for Treatment of Large Idiopathic Macular Holes
Minimal Vitrectomy and ILM Flap with Sodium Hyaluronate Gel for MH
Analysis of Novel Positioning Sensor-assisted Postoperative Position Correction and Effective Prone Time Recorded in Patients With Different Prone Times After Macular Hole Surgery
ILM Inverted Flap Size in Macular Hole
Study of Surgery in Patients With Idiopathic Macular Hole
Outcome of Surgery for Idiopathic Macular Holes
Unveiling Preclinical Idiopathic Macular Hole Formation
Trial of Prognostic Factors and Surgical Methods for the Treatment of Idiopathic Macular Holes
Outcome of Idiopathic Macular Hole
Indocyanine Green or Trypan Blue for Delamination of the Internal Limiting Membrane in Macular Hole Surgery